Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6BES

Solution structure of de novo macrocycle design11_ss

Summary for 6BES
Entry DOI10.2210/pdb6bes/pdb
NMR InformationBMRB: 30361
Descriptor(DAL)Q(DPR)(DCY)(DLY)DS(DTY)(DCY)P(DSN) (1 entity in total)
Functional Keywordsmacrocycle, de novo, de novo protein
Biological sourceHomo sapiens
Total number of polymer chains1
Total formula weight1198.33
Authors
Shortridge, M.D.,Hosseinzadeh, P.,Pardo-Avila, F.,Varani, G.,Baker, D. (deposition date: 2017-10-25, release date: 2017-12-27, Last modification date: 2024-10-09)
Primary citationHosseinzadeh, P.,Bhardwaj, G.,Mulligan, V.K.,Shortridge, M.D.,Craven, T.W.,Pardo-Avila, F.,Rettie, S.A.,Kim, D.E.,Silva, D.A.,Ibrahim, Y.M.,Webb, I.K.,Cort, J.R.,Adkins, J.N.,Varani, G.,Baker, D.
Comprehensive computational design of ordered peptide macrocycles.
Science, 358:1461-1466, 2017
Cited by
PubMed Abstract: Mixed-chirality peptide macrocycles such as cyclosporine are among the most potent therapeutics identified to date, but there is currently no way to systematically search the structural space spanned by such compounds. Natural proteins do not provide a useful guide: Peptide macrocycles lack regular secondary structures and hydrophobic cores, and can contain local structures not accessible with l-amino acids. Here, we enumerate the stable structures that can be adopted by macrocyclic peptides composed of l- and d-amino acids by near-exhaustive backbone sampling followed by sequence design and energy landscape calculations. We identify more than 200 designs predicted to fold into single stable structures, many times more than the number of currently available unbound peptide macrocycle structures. Nuclear magnetic resonance structures of 9 of 12 designed 7- to 10-residue macrocycles, and three 11- to 14-residue bicyclic designs, are close to the computational models. Our results provide a nearly complete coverage of the rich space of structures possible for short peptide macrocycles and vastly increase the available starting scaffolds for both rational drug design and library selection methods.
PubMed: 29242347
DOI: 10.1126/science.aap7577
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon